In this pitch deck, Axel Andersson and Marius Fischer present a buy recommendation on TransMedics, a disruptive medtech company redefining organ transplantation. The pitch won the inaugural Swedish University Pitch Competition of 2025 judged by Danske Bank.
In this write-up, senior analysts Linus Öberg looks at Deutsche Rohstoff AG (DRO), a €154m
German-listed upstream operator in the U.S Oil & Gas exploration and production (E&P) sector.
Despite robust fundamentals, a track record of accretive capital allocation and an exceptional
management team, the stock remains largely under the radar, trading at a significant discount to both
its peers and the intrinsic value of its reserves.
In this pitch deck, analysts Elias Hylander and Maria Sunrise provide an in-depth assessment of Fagerhult Group, a leader in professional lighting solutions with a strong focus on sustainability and innovation. Using a comprehensive valuation approach—incorporating DCF modeling, peer analysis, precedent transactions, and an LBO framework—they estimate Fagerhult’s enterprise value at SEK 11.2–15.3 billion. The following section outlines key assumptions behind this valuation and insights shaping the investment thesis.
In this pitch deck, analysts Marius Fischer, Colin Petersson, and Edvin Asplund present a comprehensive analysis of REV Group, the leading U.S. manufacturer of fire and emergency vehicles with a strong position in the RV market. Originating from a PE-backed bolt-on strategy, the company faces major operational inefficiencies and a supply/demand imbalance, positioning it for aggressive short-term margin expansion, supporting a 2-year IRR of 19% and a total upside of 42% in the base scenario.
In this pitch deck, analysts August Jörding, Emil Sköldberg, and Fredrik Sölveland provide a detailed analysis of Boot Barn, the largest Western and workwear retailer in the U.S. They highlight the company’s strong unit economics and consistent demand for western wear, justifying a target price of $234.2, reflecting a 50% upside through a DCF valuation.
In this pitch deck, analysts Erik Holst, Edvin Egnell, and David Apelryd present a detailed analysis of MGM Resorts International, highlighting its premium resort portfolio and growing BetMGM platform. Despite macroeconomic concerns, the team identifies an attractive entry point, supporting a target price of $56, reflecting a 75% upside and a three-year IRR of 29% through DCF and peer valuation methods.
In this equity research report, analysts Vilmer Larsson and Meja Wessman take a closer look at RaySearch Laboratories, a leading software provider in cancer treatment. Holding a 50% market share in proton therapy software and advancing adaptive therapy tools, RaySearch is positioned to benefit from a market growing at a 13% CAGR until 2033E. A target price of SEK 284, derived from an equally weighted DCF and peer valuation, indicates a 32% upside.
In this equity research report, analysts Adam Bursic and Måns Holmgren analyze Fodelia Oyj, a Finnish food manufacturer undergoing a strategic shift from a holding company to an active operational role. This restructuring is projected to drive a 24.4% EBIT CAGR through 2027E. Using an equally weighted DCF model, precedent transactions, and peer valuation, the target price is set at EUR 8.17 for 2026E, indicating a 30.4% upside.
In this equity research report, analyst Filippa Lostedt examines Olvi Oyj, a leading beverage company in Finland, the Baltics, and Belarus. With a strong regional presence and focus on the growing non-alcoholic segment, Olvi’s revenue is projected to grow at a 4.5% CAGR through 2026E. An equally weighted DCF and peer valuation imply a target price of EUR 47.5, suggesting a 41.0% upside.
In this equity research report, analysts Tea Nedelkovska and Krystian Segura analyze Netel, a Swedish provider of telecom, power, and infrastructure services. Leveraging an asset-light model and growing demand for 5G and clean energy, Netel’s revenue is projected to grow at a 6.2% CAGR through 2031E. Despite recent profitability declines from integration costs, a 2.5 percentage point EBIT margin expansion is expected by 2026E. A target price of SEK 23.9, based on an equally weighted DCF and peer valuation, suggests an 82.4% upside.
